California Public Employees Retirement System’s Aevi Genomic Medicine Inc GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-51,000
| Closed | -$7K | – | 3434 |
|
|
2019
Q4 | $7K | Hold |
51,000
| – | – | ﹤0.01% | 3428 |
|
|
2019
Q3 | $8K | Hold |
51,000
| – | – | ﹤0.01% | 3253 |
|
|
2019
Q2 | $8K | Hold |
51,000
| – | – | ﹤0.01% | 3250 |
|
|
2019
Q1 | $10K | Hold |
51,000
| – | – | ﹤0.01% | 3202 |
|
|
2018
Q4 | $36K | Hold |
51,000
| – | – | ﹤0.01% | 3187 |
|
|
2018
Q3 | $63K | Hold |
51,000
| – | – | ﹤0.01% | 3212 |
|
|
2018
Q2 | $57K | Hold |
51,000
| – | – | ﹤0.01% | 3221 |
|
|
2018
Q1 | $103K | Hold |
51,000
| – | – | ﹤0.01% | 3128 |
|
|
2017
Q4 | $61K | Hold |
51,000
| – | – | ﹤0.01% | 3204 |
|
|
2017
Q3 | $64K | Hold |
51,000
| – | – | ﹤0.01% | 3214 |
|
|
2017
Q2 | $68K | Hold |
51,000
| – | – | ﹤0.01% | 3245 |
|
|
2017
Q1 | $95K | Hold |
51,000
| – | – | ﹤0.01% | 3219 |
|
|
2016
Q4 | $264K | Hold |
51,000
| – | – | ﹤0.01% | 2959 |
|
|
2016
Q3 | $284K | Hold |
51,000
| – | – | ﹤0.01% | 2980 |
|
|
2016
Q2 | $283K | Hold |
51,000
| – | – | ﹤0.01% | 2996 |
|
|
2016
Q1 | $224K | Hold |
51,000
| – | – | ﹤0.01% | 3101 |
|
|
2015
Q4 | $307K | Buy |
+51,000
| New | +$346K | ﹤0.01% | 3023 |
|
California Public Employees Retirement System's GNMX Position: Q1 2020 in Review
California Public Employees Retirement System sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 51,000 shares — an estimated $7K sold.
California Public Employees Retirement System first reported a position in GNMX in Q4 2015 and held it in 17 quarters. The position peaked at $307K in Q4 2015. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.
- California Public Employees Retirement System reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
- California Public Employees Retirement System sold 51,000 Aevi Genomic Medicine Inc shares in Q1 2020, an estimated $7K.
- California Public Employees Retirement System first reported a position in Aevi Genomic Medicine Inc in Q4 2015 and held it in 17 quarters.
- California Public Employees Retirement System's Aevi Genomic Medicine Inc position peaked at $307K in Q4 2015.
- 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.
Based on California Public Employees Retirement System's 13F filing for Q1 2020, filed 12 May 2020.